Researchers have synthesized two new molecules that are able to kill Staphylococcus aureus and Pseudomonas aeruginosa — two species of bacteria…
Articles by Marisa Wexler, MS
Dosing has begun in a Phase 1 clinical trial of CM001, an inhaled treatment designed to act as a molecular…
In the months after starting on Trikafta, people with cystic fibrosis (CF) generally experience lower rates of hospitalizations…
Top-line results are expected next month for the SPAN clinical trial, a Phase 2 study testing First Wave BioPharma‘s…
Long-term treatment with Trikafta leads to sustained improvements in lung function, easing of respiratory symptoms, and better nutritional status…
Rates of screening for diabetes among people with cystic fibrosis (CF) are not where they should be, a new…
For people with cystic fibrosis (CF), key barriers to getting specialty care include concerns about addiction and affordability, according…
For people with cystic fibrosis (CF) taking Pulmozyme (dornase alfa), adding treatment with hypertonic saline — or…
Among children with cystic fibrosis (CF), lung function was seen to worsen faster following a bacterial infection with…
TAVT-135, an inhaled treatment candidate being developed for people with cystic fibrosis (CF) regardless of their underlying mutation type,…